Takeda Awards More Than $650,000 to Community Organizations through Health Equity Grant Program
March 29, 2023
Discovering and developing innovative therapies to deliver potentially transformative treatments
Listen to Takeda’s Christine Ward, Ph.D., Head of Oncology and Cell Therapy Precision & Translational Medicine, and Julie Dixon, Ph.D., Head of Global Regulatory Affairs, as they answer this question and reflect on how data, digital and technology is transforming their work and redefining possibilities for the next era of oncology.